» Articles » PMID: 17257779

Cannabis Use and Cannabis Use Disorders and Their Relationship to Mental Disorders: a 10-year Prospective-longitudinal Community Study in Adolescents

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2007 Jan 30
PMID 17257779
Citations 118
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Whereas the role of externalizing disorders is relatively well established in predicting the onset of cannabis use (CU) or cannabis use disorder (CUD), the status of anxiety and mood disorders in predicting CU and CUD remains controversial.

Objective: (1) To examine cross-sectional and prospective associations of CU and CUD with a range of mental disorders and whether anxiety and mood disorders are associated with CU/CUD after adjusting for externalizing disorders.

Methods: N=1395 community subjects aged 14-17 at baseline were followed-up at three waves prospectively over 10 years. Substance use, substance disorders and mental disorders were assessed using the DSM-IV/M-CIDI.

Results: (1) The baseline prevalence rates where 19.3% at t(0) for CU and 2.6% for CUD. Cumulative incidence rates at t(3) were 54.3% for CU and 13.7% for CUD. (2) In cross-sectional and prospective analyses other substance use disorders, mood and anxiety disorders were associated with CU and CUD. (3) Associations of panic-anxiety with CU and of depressive and bipolar disorders with CU and CUD were significant after controlling for externalizing disorders.

Conclusion: A range of psychopathological conditions, including depressive, bipolar and less consistently anxiety disorders as well as the degree of their comorbidity are significantly associated with incident CU and progression to CUD, even when controlling for externalising disorders. A better understanding of this complex interplay may result in better aetiological models and intervention strategies.

Citing Articles

Examining the Potential Impact of Recreational Cannabis Legalization on Individuals Receiving Treatment for Substance Use Disorder: An Interrupted Time Series Study in Guelph, Ontario, Canada.

Britton E, Taisir R, Cooper A, Li Y, Sousa S, Chorny Y Cannabis. 2025; 7(3):74-89.

PMID: 39781557 PMC: 11705041. DOI: 10.26828/cannabis/2024/000260.


Prevalence of substance use among a sample of patients attending an outpatient psychiatric clinic in Amman, Jordan.

Abbasi L, Daradkeh T, ElWasify M, Abassy S Discov Ment Health. 2024; 4(1):57.

PMID: 39542956 PMC: 11564451. DOI: 10.1007/s44192-024-00113-1.


Psychoactive substance use and associated factors among Mohammed first university students, Oujda, Morocco: a cross-sectional study.

Essadi A, Aissaoui H, Yeznasni A, Lekfif A, Sebbar S, Atassi M BMC Public Health. 2024; 24(1):1961.

PMID: 39044213 PMC: 11264429. DOI: 10.1186/s12889-024-19507-5.


Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study.

Lees R, Lawn W, Petrilli K, Brown A, Trinci K, Borissova A Eur Arch Psychiatry Clin Neurosci. 2024; 275(2):397-406.

PMID: 38709252 DOI: 10.1007/s00406-024-01806-y.


Cannabis use and mood disorders: a systematic review.

Sorkhou M, Dent E, George T Front Public Health. 2024; 12:1346207.

PMID: 38655516 PMC: 11035759. DOI: 10.3389/fpubh.2024.1346207.